Pulmonary
  • Asthma
  • COPD
  • Pulmonary
amPulmonary Insights
amPulmonary Insights
amPulmonary enewsletter is the hub of news and cutting-edge information for pulmonary clinicians, researchers, and medical professionals interested in the latest developments.
Topics
  • Asthma
  • COPD
  • Pulmonary
Resources
  • Subscribe
  • About Us
  • Contact Us
  • Sign In
  • Sign In
  • Asthma
  • COPD
  • Pulmonary
  • Subscribe

Pulmonary: Page 19

Study reveals extent of residual lung damage after COVID-19 hospitalization
January 10, 2023
COPD and lungs
Court order requires tobacco companies to post signs about health risks of smoking 200,000 stores across U.S.
January 10, 2023
pulmonary abstract
People living with COPD want innovation in care delivery, according to survey
Novel survey in collaboration with the COPD Foundation identifies opportunities and barriers to care for chronic disease management.
January 10, 2023
lung abstract
Sponsored
Pulmonary drug market forecast
Ascend Media
Review analysis, trends and predictions for pulmonary drug delivery systems, 2025 to 2034.
April 10, 2025
Pulmonary drug market forecast
Aria presents positive in vivo data on lead IPF treatment candidate
January 10, 2023
abstract of data
Previous Page
Page 19 of 19
Most Popular
Some COPD patients may be using the wrong inhaler
FDA approves Nucala for use in adults with COPD
Cockroach and rodent exposure linked to poor lung function in urban children with asthma
Nanoparticles carrying genetic therapies target lung cells
Oral bacterial therapy reduces respiratory infections in asthma patients
Boosting immunity with nasal vaccines
Pulmonary
Newsletter for Professionals
amPulmonary enewsletter is the hub of news and cutting-edge information for pulmonary clinicians, researchers, and medical professionals interested in the latest developments.
Topics
  • Asthma
  • COPD
  • Pulmonary
  1. Privacy Policy
  2. About Us
  3. Terms & Conditions
  4. Contact Us
  5. Site Map
© 2025 Ascend Integrated Media. All rights reserved.